One Political Plaza - Home of politics
Home Active Topics Newest Pictures Search Login Register
Main
Open Letter to: WSJ’s Editorial Board OpEd on COVID-19:
Jul 20, 2021 19:02:33   #
ACP45 Loc: Rhode Island
 
In a letter to the WSJ OpEd Board, Dr. Hooman Noorchashm said the board’s claim that people previously infected with COVID appear to be more susceptible to the Delta variant has “no basis in either current scientific epidemiological data or the fundamentals of immunology.”

The Wall Street Journal (WSJ) editorial board has published an absolute falsehood regarding the susceptibility of COVID-recovered and immune Americans to subsequent infection. This letter demanding a correction or retraction was sent to the editorial board and a few prominent WSJ reporters:

"Dear Messrs., Gigot, Murrary, Henninger and colleagues,

Today, I was shocked to read what I know, with 100% certainty as an immunologist and physician, is a lie in the WSJ’s Editorial Board OpEd on COVID-19:

Specifically, your colleagues are stating the following falsehood:

“Previously infected individuals appear to be more susceptible to re-infection by the Delta variant, which could explain some of the rising cases.”

This WSJ editorial statement is a dangerous lie, with NO basis in either current scientific epidemiological data or the fundamentals of immunology.

To the contrary, the the bulk of studies on the topic of “re-infection” in the COVID-recovered, are demonstrating that individuals who are COVID-recovered and have thus acquired antibody and T-cell immunity to SARS-CoV-2, are equally if not better protected from subsequent infection as compared to the vaccinated.
Tell Schools/Universities No Vaccine Mandates for Children/Young Adults!

Though I am cognizant this fact ought NOT be abused as an argument for seeking natural infection as a pathway to immunity, it IS the argument for not allowing coercion of COVID-recovered Americans into undergoing what is an unnecessary and potentially dangerous treatment to them.

I am left wondering why the editorial board of a respected media outlet like the WSJ would allow itself to spread such a lie with no stringent verification:

1) Are you simply careless journalists now? or

2) Are you now active participants in the U.S. Government’s publicity machine attempting to impose a “one-size-fits-all” vaccine policy on all Americans, irrespective of medical necessity, the fundamentals of immunological science and medical ethics?

Irrespective of what the reason is for the lie you have now published in today’s editorial article, it is an absolute journalistic duty for you to either correct or retract this false statement now — given that you have been alerted to it.
In a letter to the WSJ OpEd Board, Dr. Hooman Noorchashm said the board’s claim that people previously infected with COVID appear to be more susceptible to the Delta variant has “no basis in either current scientific epidemiological data or the fundamentals of immunology.”

For the WSJ to publish a critical false statement that opens the door to misleading the public and galvanizing generalist politicians and regulators into comfortably accepting unnecessary, and potentially dangerous coerced vaccination of the already immune subset of Americans, is a florid and dangerous dereliction of journalistic duty — but, of course, this seems to the norm for the mainstream media these days.

Please immediately retract your editorial board’s false statement and correct it to reflect the truth of what is known and what the science of immunology actually would predict. Your editorial piece, as it stands, promotes a very serious lie.

Originally published on Medium.
https://childrenshealthdefense.org/defender/hooman-noorchashm-immunologist-wsj-editorial-board-retract-lie-covid-immunity/?utm_source=salsa&eType=EmailBlastContent&eId=99156e28-3049-4db1-92f4-cb95564b6be3

Reply
If you want to reply, then register here. Registration is free and your account is created instantly, so you can post right away.
Main
OnePoliticalPlaza.com - Forum
Copyright 2012-2021 IDF International Technologies, Inc.